Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Leigh, E. King, C. Dumonceaux, C. Gwozd, S. Traves, M. Kelly, A. Miller-Larsson, R. Newton (Calgary, Canada; Mölndal, Sweden). Enhanced anti-inflammatory gene expression in humans following inhaled budesonide. Eur Respir J 2013; 42: Suppl. 57, 725

Member's Comments

No comment yet.

Related content which might interest you: Cytokine-induced glucocorticoid resistance: Effect on GILZ expression and reversal by formoterol Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 In vitro characterization of a novel inhaled PI3Kd inhibitor LAS194223 Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 In vitro profile of the new inhaled pan-JAK inhibitor LAS194046 Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Systemic exposure and lung bioavailability across two different dose strengths of CHF5993 a novel Triple pMDI Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 A novel inhaled PI3Kδ inhibitor, LAS194223 reduces allergen-induced airway inflammation in rat Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis Year: 2014 Tiotropium and olodaterol exert anti-proliferative effects on pulmonary fibroblasts of asthmatic patients in vitro Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 The electrophilic 17-oxo-DHA enhances the anti-inflammatory efficacy of fluticasone propionate in COPD patients Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Differential effects of budesonide and fluticasone propionate on expression of lactotransferrin in airway epithelium Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Resveratrol upregalates PTEN and inhibits MUC5AC expression in ovalbumin (OVA)-induced asthma model mice Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Antioxidant efficiency in the treatment of asthma exacerbations Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 MiR-320d: A novel anti-inflammatory miRNA up regulated by corticosteroids Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015 The anti-inflammatory effects of sulforaphane are not mediated by the Nrf2 pathway Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Safety profile and pharmacokinetics of an inhaled GATA-3-specific DNAzyme in a phase Ib study in patients with stable allergic asthma Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 Enhanced inflammatory gene expression in bronchial epithelial cells from asthmatic patients: Attenuation by a Brd4 mimic Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 Stimulation of IL-8 release in respiratory cell cultures by increasing IL1-beta concentrations: Effect of budesonide Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 In vitro pharmacological characterization of a novel p38α (MAPK14) inhibitor designed for inhaled delivery Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016 The mechanisms of anti-inflammatory action of bronchodilators Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Anti-inflammatory effect of low dose theophylline in school children with bronchial asthma Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013 Differential effects of budesonide and fluticasone propionate on bronchial epithelial barrier function Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014